November 21st, 2026Takeaways from this week in optometry: November 16-20Yuvezzi’s Health Canada submission leads this week’s recap, plus AI front desks, the EMERALD trial, and Alberta’s scope expansion.Read more
November 20th, 2026Polygenic risk flags patients likely to need more glaucoma treatment Polygenic risk scores predicted glaucoma onset and treatment course better than family history alone in a 400,000-person biobank.Read more
November 19th, 2026First patient dosed in EMERALD trial of EO2002 for corneal edemaThe phase 2 EMERALD trial compares 2 doses of EO2002 with placebo, with a 15-letter BCVA gain at 26 weeks as the primary end point.Read more
November 18th, 2026The Independent Advantage S02 E11: AI-powered front desks: Now and in the futureWill AI reinvent the way patients book appointments in the next 5 years? Raphael Rostenne weighs in in the season 2 finale of The Independent Advantage.Read more
November 13th, 2026Nicholas Garn, OD, on opening an OD-owned surgery suite in IndianaIn this Q&A, Nicholas Garn, OD, discusses surgeon contracts, cost planning, and sharing surgical time at his OD-owned suite in Indiana.Read more
November 11th, 2026The Independent Advantage S02 E10: Demoing AI voice agentsRaphael Rostenne walks Diana Canto-Sims, OD, through demos on EyeCarePro's AI voice agent for fielding phone calls.Read more
November 10th, 2026Paul Barney, OD, on caring for veterans, VA optometry scopeAhead of Veterans Day, Paul Barney, OD, urges optometrists to watch for combat- and trauma-related eye injuries in veterans.Read more
November 4th, 2026Indiana optometrists open state’s first OD-owned surgical suitesChristopher Browning, OD, and Nicholas Garn, OD, now offer cataract surgery and refractive lens exchange in their own practices.Read more